Fresenius | FRE - Loan Capital


Fresenius reported EUR9.55B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Akzo Nobel EUR 5.5B 743M Jun/2026
Alcon AG USD 4.16B 434M Mar/2026
AstraZeneca USD 26.01B 46M Jun/2026
BASF EUR 18.83B 1.08B Jun/2026
Bayer EUR 30.68B 1.15B Mar/2026
Beiersdorf EUR 117M 15M Dec/2025
DaVita Healthcare Partners USD 10.51B 349.61M Mar/2026
Demant DKK 18.98B 3.71B Dec/2025
E.ON EUR 36.53B 2.47B Mar/2026
Essilor EUR 9.66B 190M Jun/2026
Fresenius EUR 9.55B 1.24B Jun/2026
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Getinge SEK 9.09B 167M Jun/2026
Givaudan CHF 4.19B 448M Dec/2025
GlaxoSmithKline GBP 13.95B 65M Jun/2026
GN Store Nord DKK 8.1B 790M Mar/2026
GRIFOLS EUR 7.17B 1.91B Jun/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.49B 42M Jun/2026
Philips EUR 6.32B 575M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
RWE EUR 16.43B 917M Mar/2026
Sanofi EUR 14.65B 806M Jun/2026
Smith & Nephew USD 3.21B 85M Jun/2026